PortfoliosLab logoPortfoliosLab logo
AHCO vs. ANAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AHCO vs. ANAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AdaptHealth Corp. (AHCO) and AnaptysBio, Inc. (ANAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AHCO achieves a -2.41% return, which is significantly lower than ANAB's 58.54% return.


AHCO

1D
0.73%
1M
-25.46%
YTD
-2.41%
6M
4.07%
1Y
9.71%
3Y*
-2.54%
5Y*
-17.74%
10Y*

ANAB

1D
-0.04%
1M
-26.57%
YTD
58.54%
6M
75.64%
1Y
226.79%
3Y*
60.13%
5Y*
27.51%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AHCO vs. ANAB - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
AHCO
AdaptHealth Corp.
-2.41%4.62%30.59%-62.07%-21.42%-34.88%242.08%11.70%1.34%
ANAB
AnaptysBio, Inc.
58.54%266.16%-38.19%-30.88%-10.82%61.63%32.31%-74.53%-22.84%

Correlation

The correlation between AHCO and ANAB is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since May 25, 2018

0.14

Fundamentals

Market Cap

AHCO:

$1.32B

ANAB:

$1.47B

EPS

AHCO:

-$0.60

ANAB:

-$0.91

PS Ratio

AHCO:

0.43

ANAB:

6.50

PB Ratio

AHCO:

0.87

ANAB:

115.33

Total Revenue (TTM)

AHCO:

$3.08B

ANAB:

$232.39M

Gross Profit (TTM)

AHCO:

$260.17M

ANAB:

$245.59M

EBITDA (TTM)

AHCO:

$380.93M

ANAB:

$52.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AHCO vs. ANAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AHCO
AHCO Risk / Return Rank: 4848
Overall Rank
AHCO Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
AHCO Sortino Ratio Rank: 4646
Sortino Ratio Rank
AHCO Omega Ratio Rank: 4545
Omega Ratio Rank
AHCO Calmar Ratio Rank: 4949
Calmar Ratio Rank
AHCO Martin Ratio Rank: 5353
Martin Ratio Rank

ANAB
ANAB Risk / Return Rank: 9494
Overall Rank
ANAB Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
ANAB Sortino Ratio Rank: 9393
Sortino Ratio Rank
ANAB Omega Ratio Rank: 9292
Omega Ratio Rank
ANAB Calmar Ratio Rank: 9696
Calmar Ratio Rank
ANAB Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AHCO vs. ANAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AdaptHealth Corp. (AHCO) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AHCOANABDifference

Sharpe ratio

Return per unit of total volatility

0.21

3.24

-3.03

Sortino ratio

Return per unit of downside risk

0.67

3.63

-2.96

Omega ratio

Gain probability vs. loss probability

1.08

1.48

-0.40

Calmar ratio

Return relative to maximum drawdown

0.35

8.11

-7.76

Martin ratio

Return relative to average drawdown

1.06

20.93

-19.88

AHCO vs. ANAB - Sharpe Ratio Comparison

The current AHCO Sharpe Ratio is 0.21, which is lower than the ANAB Sharpe Ratio of 3.24. The chart below compares the historical Sharpe Ratios of AHCO and ANAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AHCOANABDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.21

3.24

-3.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.31

0.42

-0.73

Sharpe Ratio (All Time)

Calculated using the full available price history

0.00

0.23

-0.23

Drawdowns

AHCO vs. ANAB - Drawdown Comparison

The maximum AHCO drawdown since its inception was -83.84%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for AHCO and ANAB.


Loading charts...

Drawdown Indicators


AHCOANABDifference

Max Drawdown

Largest peak-to-trough decline

-83.84%

-92.08%

+8.24%

Max Drawdown (1Y)

Largest decline over 1 year

-27.88%

-28.15%

+0.27%

Max Drawdown (3Y)

Largest decline over 3 years

-56.06%

-69.32%

+13.26%

Max Drawdown (5Y)

Largest decline over 5 years

-78.29%

-69.32%

-8.97%

Current Drawdown

Current decline from peak

-75.79%

-40.21%

-35.58%

Average Drawdown

Average peak-to-trough decline

-43.23%

-64.74%

+21.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.21%

10.92%

-1.71%

Volatility

AHCO vs. ANAB - Volatility Comparison

AdaptHealth Corp. (AHCO) has a higher volatility of 12.42% compared to AnaptysBio, Inc. (ANAB) at 11.47%. This indicates that AHCO's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AHCOANABDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.42%

11.47%

+0.95%

Volatility (6M)

Calculated over the trailing 6-month period

33.27%

46.57%

-13.30%

Volatility (1Y)

Calculated over the trailing 1-year period

46.49%

70.75%

-24.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.22%

65.34%

-7.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.80%

75.51%

-20.71%

Dividends

AHCO vs. ANAB - Dividend Comparison

Neither AHCO nor ANAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AHCO vs. ANAB - Financials Comparison

This section allows you to compare key financial metrics between AdaptHealth Corp. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
819.80M
25.56M
(AHCO) Total Revenue
(ANAB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AHCO and ANAB have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AHCO has higher volatility (12.42%) compared to ANAB (11.47%). In terms of maximum drawdown, AHCO dropped -83.84% vs ANAB's -92.08%.

ANAB currently has the higher Sharpe Ratio (3.24 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AHCO and ANAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer